BioForce Nanosciences (PK) (USOTC:BFNH)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more BioForce Nanosciences (PK) Charts. Click Here for more BioForce Nanosciences (PK) Charts.](/p.php?pid=staticchart&s=NO%5EBFNH&p=8&t=15)
BioForce Nanosciences Holdings, Inc. (OTC BB: BFNH), a leader in systems
integration at the micro- and nano-scales to create products for the
life sciences, is pleased to announce that European distributor
NanoAndMore GmbH has completed the sale of a Nano eNabler™
System at the Italian Institute of Technology in Genova. The instrument
is scheduled to be installed in the Department of Neuroscience and Brain
Technologies (NBT), led by Professor Fabio Benfenati.
With this completion of their fourth sale in Continental Europe,
NanoAndMore GmbH CEO Peer Burshille reports that they continue to
encounter strong interest in the Nano eNabler benchtop molecular
printer. Mr. Burshille added, “I am encouraged
by the enthusiastic response we are receiving in Europe about the Nano
eNabler and I feel very confident that the current surge of interest is
the beginning of a trend. The addition of the new Cyto eNabler™
System to this line of products is, in my opinion, a wise move to extend
the capabilities of the technology and reach out to an ever widening
audience of customers.”
Kerry Frey, President and Chief Executive Officer of BioForce
Nanosciences, said, “We are very happy with
NanoAndMore’s success. They are a key
component of our worldwide network of distributors that is responsible
for sales of our products outside the US. This network operates in all
major scientific research markets and complements our US in-house sales
force.”
BioForce recently announced the addition of the Cyto eNabler System, an
instrument custom tailored to the needs of the cell biology market, to
its product line. This new device offers a user friendly entry into
surface patterning for customers focused on stem cell research, tissue
engineering, and the development of live cell assays to hasten the drug
discovery process. The original Nano eNabler remains the premier model,
with capabilities that are ideal for developing new biosensor concepts
into useful diagnostic devices. Its nanoscale precision and versatility
to deposit virtually any biomaterial onto sensor surfaces remains
unmatched by any other technology.
About BioForce Nanosciences Holdings Inc.
BioForce Nanosciences creates products and solutions for the life
sciences by integrating biological and mechanical systems at the micro
and nano scales. BioForce’s flagship product,
the Nano eNabler™ molecular printer, gives
the Company and its customers a platform for development and discovery
by printing tiny domains of biological materials on surfaces with
nanometer spatial precision. BioForce technology is being used in areas
such as biosensor functionalization; pattering and cell adhesion; and
the printing of proteins to guide neural cell growth. For more
information, visit www.bioforcenano.com
or call 515-233-8333.
This news release contains forward-looking information that may be
affected by certain risks and uncertainties, including those risks and
uncertainties described in BioForce Nanosciences' most recent filings
with the Securities and Exchange Commission. BioForce Nanosciences'
actual results could differ materially from such forward-looking
statements. BioForce assumes no duty to update these statements at any
future date.